TRIGGIANESE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 18.543
AS - Asia 3.582
EU - Europa 2.507
Continente sconosciuto - Info sul continente non disponibili 450
SA - Sud America 445
AF - Africa 94
OC - Oceania 87
Totale 25.708
Nazione #
US - Stati Uniti d'America 18.342
SG - Singapore 1.603
CN - Cina 754
IT - Italia 527
RU - Federazione Russa 412
BR - Brasile 354
HK - Hong Kong 352
VN - Vietnam 244
DE - Germania 242
IE - Irlanda 221
FR - Francia 213
GB - Regno Unito 188
FI - Finlandia 180
BD - Bangladesh 153
UA - Ucraina 138
CA - Canada 108
JP - Giappone 107
SE - Svezia 87
IN - India 66
NL - Olanda 58
PL - Polonia 51
KR - Corea 46
AU - Australia 44
NZ - Nuova Zelanda 43
ID - Indonesia 40
DK - Danimarca 38
ES - Italia 35
TW - Taiwan 35
BE - Belgio 32
MX - Messico 32
TR - Turchia 32
AR - Argentina 31
ZA - Sudafrica 28
EG - Egitto 26
AT - Austria 22
SA - Arabia Saudita 20
EC - Ecuador 18
IR - Iran 15
CR - Costa Rica 13
JM - Giamaica 13
CO - Colombia 12
MA - Marocco 12
PH - Filippine 12
UZ - Uzbekistan 12
IQ - Iraq 11
LV - Lettonia 11
MY - Malesia 11
AE - Emirati Arabi Uniti 10
NP - Nepal 10
PK - Pakistan 10
LT - Lituania 8
CH - Svizzera 7
NG - Nigeria 7
VE - Venezuela 7
CL - Cile 6
PE - Perù 6
RO - Romania 6
TH - Thailandia 6
ET - Etiopia 5
GT - Guatemala 5
NI - Nicaragua 5
PY - Paraguay 5
SI - Slovenia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
HU - Ungheria 4
IL - Israele 4
KE - Kenya 4
LB - Libano 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
EE - Estonia 3
HN - Honduras 3
KZ - Kazakistan 3
PR - Porto Rico 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
YE - Yemen 3
AL - Albania 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KH - Cambogia 2
KW - Kuwait 2
NO - Norvegia 2
PA - Panama 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
Totale 25.245
Città #
Wilmington 4.098
Houston 3.659
Woodbridge 3.367
Singapore 878
Ashburn 770
Fairfield 551
Ann Arbor 473
San Jose 407
Chandler 382
Hong Kong 344
Dallas 249
Seattle 248
Beijing 247
Council Bluffs 213
New York 194
Cambridge 180
Dublin 174
Santa Clara 156
Rome 145
Los Angeles 137
Medford 136
The Dalles 135
Helsinki 131
Ho Chi Minh City 99
Jacksonville 95
Tokyo 79
Moscow 64
Lawrence 63
Lauterbourg 60
Denver 57
Buffalo 56
Hanoi 53
São Paulo 51
North Bergen 50
Chicago 48
Zhengzhou 48
Dearborn 46
London 45
Redwood City 44
Tauranga 42
Toronto 39
Copenhagen 33
Orem 33
Munich 32
Brooklyn 31
Phoenix 31
Nanjing 30
Kraków 29
Amsterdam 28
Boardman 28
Brussels 28
Atlanta 27
Jakarta 27
Milan 27
Nuremberg 27
Chengdu 24
San Diego 24
Shanghai 24
Shenzhen 24
Johannesburg 23
Seoul 22
Stockholm 22
Taipei 22
Montreal 21
Redondo Beach 21
Melbourne 20
Menlo Park 20
Warsaw 20
Suzhou 19
Frankfurt am Main 18
Las Vegas 18
Naples 18
Norwalk 17
San Francisco 17
Chennai 16
Guangzhou 16
Jeddah 16
Columbus 14
Springfield 14
Palo Alto 13
Scottsdale 13
Bassano del Grappa 12
Boston 12
Brasília 12
Mumbai 12
Philadelphia 12
Tanta 12
Lappeenranta 11
Manchester 11
Center 10
Charlotte 10
Chongqing 10
Florence 10
Istanbul 10
Kunming 10
Monte Porzio Catone 10
Ankara 9
Cairo 9
Haiphong 9
Hefei 9
Totale 19.420
Nome #
Challenges in the treatment of Rheumatoid Arthritis 906
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 675
Complement, infection, and autoimmunity 620
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 544
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 535
Autoantibodies in inflammatory arthritis 526
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 521
Vasculitides and the Complement System: a Comprehensive Review 515
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 485
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 485
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 483
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 481
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 480
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 479
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 471
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 471
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 468
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 467
Auto-reactions, autoimmunity and psoriatic arthritis 448
HELLP syndrome: A complication or a new autoimmune syndrome? 446
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 442
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 442
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 435
The interplay between inflammation and metabolism in rheumatoid arthritis 427
Insights on the role of physical activity in patients with rheumatoid arthritis 422
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 421
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 407
Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes 407
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature 386
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 366
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study 357
Hereditary angioedema and autoimmunity 356
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 351
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 348
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 345
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 326
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 322
Interaction between microbiome and host genetics in psoriatic arthritis 318
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 296
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 287
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 277
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 268
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 265
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 252
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 244
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 235
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 234
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 220
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 216
Severe lupus nephritis: an unexpected association with Fabry disease 206
Vitamin D deficiency in an Italian cohort of infertile women 199
A rare but fatal behçet variant: the hughes–stovin syndrome—successful case report and new evidence from literature review 195
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 194
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 189
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 183
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 182
COVID-19: disCOVering the role of complement system 177
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 172
Tackling the autoimmune side in Spondyloarthritis: a systematic review 163
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 162
Innate lymphoid cells: a potential innate functional equivalent of adaptive cells in infertility and inflammatory arthropathies 158
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 141
The steroid-sparing effect of JAK inhibitors across multiple patient populations 136
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 123
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 120
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 117
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 117
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 115
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 115
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections 105
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 104
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 104
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 102
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 98
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 96
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 94
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 94
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 89
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 89
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry (Internal and Emergency Medicine, (2023), 18, 8, (2231-2243), 10.1007/s11739-023-03408-3) 86
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 86
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 85
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 85
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease 83
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 82
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 80
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies 80
Kidney–Lung Crosstalk in Acute Nephrologic Involvement: Mechanisms, Complement Activation, and Implications for Multiorgan Dysfunction 78
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis 76
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 76
Subclinical signs of retinal involvement in hereditary angioedema 75
Psoriatic Arthritis in Males and Females: Differences and Similarities 70
Unexpected genomic architecture in a sporadic case of C1-INH Hereditary Angioedema: the hidden heritability 69
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor 65
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 60
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 55
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 49
Reduced retinal microvascular density in patients with mixed connective tissue disease: an exploratory pilot study on the interplay between aging, renal function, and complement system 27
An Italian cartography of VEXAS‐related thrombosis 24
Totale 25.708
Categoria #
all - tutte 71.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022548 0 0 0 39 37 43 36 39 37 61 83 173
2022/2023955 88 78 49 126 86 204 80 69 95 18 36 26
2023/2024453 38 16 20 13 70 103 14 48 22 25 23 61
2024/20252.445 74 478 311 134 37 233 104 120 198 193 329 234
2025/20265.011 335 239 622 505 467 200 680 494 476 455 296 242
2026/20272.045 290 404 772 579 0 0 0 0 0 0 0 0
Totale 25.708